BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

479 related articles for article (PubMed ID: 31541465)

  • 1. MTSS1 hypermethylation is associated with prostate cancer progression.
    Chen J; Huang L; Zhu Q; Wang Z; Tang Z
    J Cell Physiol; 2020 Mar; 235(3):2687-2697. PubMed ID: 31541465
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PON1 hypermethylation is associated with progression of renal cell carcinoma.
    Li X; Yu Q
    J Cell Mol Med; 2019 Oct; 23(10):6646-6657. PubMed ID: 31400051
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inactivation of ADAMTS18 by aberrant promoter hypermethylation contribute to lung cancer progression.
    Zhang Y; Xu H; Mu J; Guo S; Ye L; Li D; Peng W; He X; Xiang T
    J Cell Physiol; 2019 May; 234(5):6965-6975. PubMed ID: 30417422
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MicroRNA-135b regulates metastasis suppressor 1 expression and promotes migration and invasion in colorectal cancer.
    Wu W; Wang Z; Yang P; Yang J; Liang J; Chen Y; Wang H; Wei G; Ye S; Zhou Y
    Mol Cell Biochem; 2014 Mar; 388(1-2):249-59. PubMed ID: 24343340
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ECRG4 acts as a tumor suppressor gene frequently hypermethylated in human breast cancer.
    Tang GY; Tang GJ; Yin L; Chao C; Zhou R; Ren GP; Chen JY; Zhang W
    Biosci Rep; 2019 May; 39(5):. PubMed ID: 30918105
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long non-coding RNA VIM-AS1 promotes prostate cancer growth and invasion by regulating epithelial-mesenchymal transition.
    Zhang Y; Zhang J; Liang S; Lang G; Liu G; Liu P; Deng X
    J BUON; 2019; 24(5):2090-2098. PubMed ID: 31786880
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Methylation of CLEC14A is associated with its expression and lung adenocarcinoma progression.
    Su C; Shi K; Cheng X; Han Y; Li Y; Yu D; Liu Z
    J Cell Physiol; 2019 Mar; 234(3):2954-2962. PubMed ID: 30191970
    [TBL] [Abstract][Full Text] [Related]  

  • 8. miR-326 functions as a tumor suppressor in human prostatic carcinoma by targeting Mucin1.
    Liang X; Li Z; Men Q; Li Y; Li H; Chong T
    Biomed Pharmacother; 2018 Dec; 108():574-583. PubMed ID: 30243091
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oncogenic microRNA-4534 regulates PTEN pathway in prostate cancer.
    Nip H; Dar AA; Saini S; Colden M; Varahram S; Chowdhary H; Yamamura S; Mitsui Y; Tanaka Y; Kato T; Hashimoto Y; Shiina M; Kulkarni P; Dasgupta P; Imai-Sumida M; Tabatabai ZL; Greene K; Deng G; Dahiya R; Majid S
    Oncotarget; 2016 Oct; 7(42):68371-68384. PubMed ID: 27634912
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MicroRNA-182-5p promotes cell invasion and proliferation by down regulating FOXF2, RECK and MTSS1 genes in human prostate cancer.
    Hirata H; Ueno K; Shahryari V; Deng G; Tanaka Y; Tabatabai ZL; Hinoda Y; Dahiya R
    PLoS One; 2013; 8(1):e55502. PubMed ID: 23383207
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epigenetic silencing of Aristaless-like homeobox-4, a potential tumor suppressor gene associated with lung cancer.
    Liu WB; Han F; Du XH; Jiang X; Li YH; Liu Y; Chen HQ; Ao L; Cui ZH; Cao J; Liu JY
    Int J Cancer; 2014 Mar; 134(6):1311-22. PubMed ID: 24037716
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The 3p14.2 tumour suppressor ADAMTS9 is inactivated by promoter CpG methylation and inhibits tumour cell growth in breast cancer.
    Shao B; Feng Y; Zhang H; Yu F; Li Q; Tan C; Xu H; Ying J; Li L; Yang D; Peng W; Tang J; Li S; Ren G; Tao Q; Xiang T
    J Cell Mol Med; 2018 Feb; 22(2):1257-1271. PubMed ID: 29193730
    [TBL] [Abstract][Full Text] [Related]  

  • 13. miR-96 promotes the growth of prostate carcinoma cells by suppressing MTSS1.
    Xu L; Zhong J; Guo B; Zhu Q; Liang H; Wen N; Yun W; Zhang L
    Tumour Biol; 2016 Sep; 37(9):12023-12032. PubMed ID: 27164937
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epigenetic inactivation of HOXD10 is associated with human colon cancer via inhibiting the RHOC/AKT/MAPK signaling pathway.
    Yuan YH; Wang HY; Lai Y; Zhong W; Liang WL; Yan FD; Yu Z; Chen JK; Lin Y
    Cell Commun Signal; 2019 Jan; 17(1):9. PubMed ID: 30683109
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The biological functions and mechanism of miR‑212 in prostate cancer proliferation, migration and invasion via targeting Engrailed-2.
    Zhou Y; Ji Z; Yan W; Zhou Z; Li H
    Oncol Rep; 2017 Sep; 38(3):1411-1419. PubMed ID: 28713997
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A reciprocal feedback of Myc and lncRNA MTSS1-AS contributes to extracellular acidity-promoted metastasis of pancreatic cancer.
    Hu Y; Wang F; Xu F; Fang K; Fang Z; Shuai X; Cai K; Chen J; Hu P; Chen D; Xu P; Hu C; Zeng Z; Zhong J; Li W; Tang J; Huang M; Zhao Y; Wang C; Zhao G
    Theranostics; 2020; 10(22):10120-10140. PubMed ID: 32929338
    [No Abstract]   [Full Text] [Related]  

  • 17. Reduced Expression of Metastasis Suppressor-1 (MTSS1) Accelerates Progression of Human Bladder Uroepithelium Cell Carcinoma.
    Du P; Wang S; Tang X; An C; Yang Y; Jiang WG
    Anticancer Res; 2017 Aug; 37(8):4499-4505. PubMed ID: 28739745
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HORMAD2 methylation-mediated epigenetic regulation of gene expression in thyroid cancer.
    Lin Q; Hou S; Guan F; Lin C
    J Cell Mol Med; 2018 Oct; 22(10):4640-4652. PubMed ID: 30039914
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting the unique methylation pattern of androgen receptor (AR) promoter in prostate stem/progenitor cells with 5-aza-2'-deoxycytidine (5-AZA) leads to suppressed prostate tumorigenesis.
    Tian J; Lee SO; Liang L; Luo J; Huang CK; Li L; Niu Y; Chang C
    J Biol Chem; 2012 Nov; 287(47):39954-66. PubMed ID: 23012352
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulation of SPDEF expression by DNA methylation in advanced prostate cancer.
    Vatanmakanian M; Steffan JJ; Koul S; Ochoa AC; Chaturvedi LS; Koul HK
    Front Endocrinol (Lausanne); 2023; 14():1156120. PubMed ID: 37900138
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.